Study to Evaluate the Safety,Tolerability and Pharmacokinetics of a New Formulation of Oritavancin in Healthy Volunteers
Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
The protocol describes a double-blind study to evaluate the Pharmacokinetics and safety of a
new formulation of oritavancin by adjusting infusion time, concentration and
reconstitution/administration solutions, of a single 1200 mg intravenous (IV) infusion of
oritavancin